Innovent Presents Phase 3 DREAMS-1 Study of Mazdutide at ADA 85th
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and...